Aspirin or resveratrol treatment decreased expression of eosinophil-associated inflammation markers in MT-COMP growth plate chondrocytes. Immunostaining of P28 growth plates from control and MT-COMP mice treated with either aspirin or resveratrol from P0 to P28. EPX, ECF-L and IL16 immunostaining is shown for control mice (A–C, G–I, M–O) and for MT-COMP mice (D–F, J–L, P–R). Growth plates from at least 8 mice were examined for each treatment. Bar = 100 µm.